Concepedia

Sheng Xiao

SX

Statistics

Publications

16

Citations

2.5K

H-Index

12

Active since

1998

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Central South University

Dana-Farber Cancer Institute

Soochow University

Sheng Xiao is an author at Brigham and Women's Hospital specializing in oncology, molecular oncology, and life sciences.

Publications per year

1998–2024

16

Publications

16

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

Brian P. Rubin, Samuel Singer, C. Tsao et al. · PubMed · 2001 · 969 citations

Medicine, Oncology, Pathology +17

TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors

Brandon D. Lawrence, Antonio R. Pérez‐Atayde, M K Hibbard et al. · American Journal Of Pathology · 2000 · 716 citations · Full text

Medicine, Cancer Biology, Oncology +11

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

Sheng Xiao, Srinivasa Nalabolu, Jon C. Aster et al. · Nature Genetics · 1998 · 327 citations

Life Sciences, Genetics, Molecular Genetics +13

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder

Jing Chen, Daniel J. DeAngelo, Jeffery L. Kutok et al. · Proceedings of the National Academy of Sciences · 2004 · 172 citations

Medicine, Oncology, Pharmacology +17

ZNF198–FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain

Sheng Xiao, J.G. McCarthy, Jon C. Aster et al. · Blood · 2000 · 74 citations

Life Sciences, Cell Biology, Molecular Biology +5

1–5 of 16